[Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
Placental Protein 12 (PP 12) concentrations were measured by a radioimmunoassay in cyst and peritoneal fluids and in serum samples respectively of patients with tumor like conditions and benign and malignant cystic ovarian tumours. PP 12 can not recommended as a serum tumour marker in ovarian cancer. It must be proved the value of PP 12 in follow up of ovarian cancer with help of more extensive sample material. There are many cysts in tumour like conditions with measurable PP 12-concentrations.
Frauenklinik, des Bezirkskrankenhauses Wismar.
R R
RR
Strache
P M
PM
Göcze
D G
DG
Szábo
H H
HH
Büttner
V
V
Briese
M
M
Kunze
I F
IF
Csaba
G
G
Röpcke
D001202:Ascitic Fluid / Q000032:analysis*; D002352:Carrier Proteins / Q000097:blood*; D003536:Cystadenocarcinoma / Q000175:diagnosis; D003537:Cystadenoma / Q000175:diagnosis; D003884:Dermoid Cyst / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1; D018969:Insulin-Like Growth Factor Binding Proteins; D010048:Ovarian Cysts / Q000097:blood / Q000175:diagnosis*; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis*; D011257:Pregnancy Proteins / Q000097:blood*; D011863:Radioimmunoassay
D002352:Carrier Proteins; C032231:IGFBP1 protein, human; D018970:Insulin-Like Growth Factor Binding Protein 1; D018969:Insulin-Like Growth Factor Binding Proteins; D011257:Pregnancy Proteins
Das Plazentaprotein 12 (PP 12) in zysten- und Peritonealflüssigkeiten sowie Serumproben von Patientinnen mit Ovarialzysten und zystischen Ovarialtumoren.